Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-28 Sale |
2021-06-01 7:15 pm |
MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director |
7,142 | $28.99 | $207,023 | 13,420 (Direct) |
View |
| 2021-05-27 Sale |
2021-05-28 6:48 pm |
MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director |
15,889 | $0 | $0 | 20,562 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 7:45 pm |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
19,360 | $31.97 | $618,949 | 334,562 (Direct) |
View |
| 2021-04-27 Sale |
2021-04-28 5:10 pm |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
40,000 | $31.47 | $1,258,800 | 353,922 (Direct) |
View |
| 2021-04-19 Sale |
2021-04-20 5:18 pm |
MYRIAD GENETICS INC | MYGN | Lambert Nicole See Remarks |
6,649 | $27.01 | $179,586 | 129,119 (Direct) |
View |
| 2021-03-29 Sale |
2021-03-30 6:31 pm |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
58,000 | $30 | $1,740,000 | 80,128 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 4:46 pm |
MYRIAD GENETICS INC | MYGN | Riggsbee Richard Bryan Chief Financial Officer |
11,175 | $29.69 | $331,786 | 307,151 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 6:10 pm |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
80,000 | $29.71 | $2,377,048 | 246,575 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-11 4:40 pm |
MYRIAD GENETICS INC | MYGN | Parkinson Paul EVP Strategy and Innovation |
11,824 | $25 | $295,600 | 76,746 (Direct) |
View |
| 2020-11-11 Purchase |
2020-11-12 08:57 am |
MYRIAD GENETICS INC | MYGN | Phanstiel S. Louise Director |
15,000 | $16.62 | $249,336 | 71,790 (Indirect Direct) |
View |
| 2020-10-31 Sale |
2020-11-02 9:22 pm |
MYRIAD GENETICS INC | MYGN | Parkinson Paul EVP Strategy and Innovation |
2,218 | $12.43 | $27,570 | 88,570 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-28 Option Award |
2021-06-03 6:45 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
1,082 | $15.86 | 81,210 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-03 6:42 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Haas Kevin Richard Chief Technology Officer |
344 | $15.86 | 56,113 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-05 7:45 pm |
N/A 2021-09-13 |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
19,360 | $0 | 334,562 (Direct) |
View |
| 2021-05-04 Exercise |
2021-05-05 7:45 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
19,360 | $19.47 | 334,562 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-28 5:10 pm |
N/A 2021-09-13 |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
40,000 | $0 | 353,922 (Direct) |
View |
| 2021-04-27 Exercise |
2021-04-28 5:10 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
40,000 | $19.47 | 353,922 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 11:23 am |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Santa Eric Chief Growth Officer |
16,420 | $0 | 16,420 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-30 6:31 pm |
N/A 2021-05-25 |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
58,000 | $0 | 80,128 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-30 6:31 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
28,000 | $19.47 | 80,128 (Direct) |
View |
| 2021-03-29 Exercise |
2021-03-30 6:31 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
30,000 | $24.89 | 80,128 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 5:22 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | DIAZ PAUL J President and CEO |
159,915 | $0 | 458,869 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:45 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Chief People Officer |
13,326 | $0 | 80,128 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:41 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Jackson Benjamin E.V.P., General Counsel |
18,879 | $0 | 107,029 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:37 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Parkinson Paul EVP Strategy and Innovation |
10,661 | $0 | 87,407 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:33 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Haas Kevin Richard Chief Technology Officer |
13,326 | $0 | 55,769 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:30 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
19,347 | $0 | 265,922 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:23 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
15,441 | $0 | 157,130 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:19 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Lambert Nicole President, Myriad Oncology, |
29,556 | $0 | 135,768 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-26 4:15 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Riggsbee Richard Bryan Chief Financial Officer |
32,774 | $0 | 339,925 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 4:43 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Ancona Margaret SVP Enterprise Transformation |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 4:38 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Haas Kevin Richard SVP Technology |
10,000 | $0 | 42,443 (Direct) |
View |
Ownership |
2021-02-22 4:36 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Haas Kevin Richard SVP Technology |
0 | $0 | 32,443 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-17 6:10 pm |
N/A 2021-02-23 |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
80,000 | $0 | 246,575 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-17 6:10 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | LANCHBURY JERRY S Chief Scientific Officer |
80,000 | $18 | 246,575 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 6:44 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Reitan Colleen F Director |
15,889 | $0 | 27,576 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 6:41 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Skovronsky Daniel Director |
15,889 | $0 | 40,930 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 5:27 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | SPIEGELMAN DANIEL K Director |
15,889 | $0 | 36,451 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 5:24 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Newcomer Lee Nisley Director |
15,889 | $0 | 27,576 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 5:14 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | LANGER DENNIS Director |
15,889 | $0 | 76,679 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 5:11 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | DREISMANN HEINRICH Director |
15,889 | $0 | 70,679 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 5:09 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Phanstiel S. Louise Director |
15,889 | $0 | 87,679 (Direct) |
View |
| 2020-10-08 Option Award |
2020-10-13 08:21 am |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Hart Jayne B. Executive VP Human Resources |
17,853 | $0 | 66,802 (Direct) |
View |
| 2020-10-08 Option Award |
2020-10-13 08:19 am |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Parkinson Paul EVP Strategy and Innovation |
21,730 | $0 | 90,788 (Direct) |
View |